45 results
8-K
EX-99.1
kiyd7d1 2mzei
24 Apr 23
UNITY Biotechnology Announces Positive 48-Week Results from Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:05am
424B5
fkc26 pcdw1
13 May 22
Prospectus supplement for primary offering
4:18pm
PRE 14A
w4z qta8ycr7
12 Apr 22
Preliminary proxy
4:02pm
424B5
si13bxjcz0
29 Sep 21
Prospectus supplement for primary offering
5:24pm
8-K/A
EX-99.2
gecpw2o5s iafxq
7 Jul 21
Financial Statements and Exhibits
8:00am
8-K
EX-99.1
2ksdt8vb0jhyh3qv
6 Jul 21
UNITY Biotechnology Announces Positive Data from Phase 1 Clinical Trial of UBX1325 in Patients with Advanced Vascular Eye Disease
7:11am